Costamare declares quarterly common and preferred dividends
Costamare (NYSE:CMRE) declared a quarterly common-stock dividend of $0.125 per share for the quarter ended September 30, 2026.
Costamare (NYSE:CMRE) declared a quarterly common-stock dividend of $0.125 per share for the quarter ended September 30, 2026.
National Fuel Gas Company (NYSE:NFG) completed its acquisition of CenterPoint Energy’s Ohio natural gas utility business, Vectren Energy Delivery of Ohio, expanding its regulated utility operations.
Brookfield (NYSE:BAM) announced the final close of Oaktree’s inaugural Asset-Backed Finance Fund, with total commitments of $2 billion across the fund and related investment vehicles.
Namib Minerals (NASDAQ:NAMM) reported first-half 2026 financial results, with higher gold prices supporting revenue and operating performance despite lower production levels.
nVent Electric (NYSE:NVT) completed its acquisition of Maverick Power, a manufacturer of engineered power distribution and infrastructure solutions for data centers, for a purchase price of $1.75 billion, subject to customary adjustments.
Novo Nordisk (NYSE:NVO) presented exploratory analyses from the STEP UP program showing that Wegovy (semaglutide) was associated with reductions in liver fat among adults with obesity who did not have diabetes.
Cardinal Health (NYSE:CAH) entered into a binding letter of intent with CVS Health to extend their existing pharmaceutical distribution agreement through June 30, 2032.
Agomab (NASDAQ:AGMB) reported topline results from the STENOVA open-label extension study of ontunisertib in patients with fibrostenosing Crohn’s disease, with 49 patients completing the 48-week extension period.
Origin Agritech (NASDAQ:SEED) entered into an agreement to sell its principal corn seed production subsidiary stake as part of a transaction involving Xinjiang Originbo.
Anastasia Amoroso, Chief Investment Strategist of Partners Group, joins Bloomberg's Vonnie Quinn on "Bloomberg Brief" to discuss the US Challenger September job cuts data along with the rise of yields.
Shattuck Labs (NASDAQ:STTK) announced plans to evaluate SL-325 in a Phase 2 clinical trial for patients with moderate to severe hidradenitis suppurativa (HS), expanding the program beyond its existing inflammatory bowel disease development.
CenterPoint Energy (NYSE:CNP) completed the sale of its Ohio natural gas distribution business, Vectren Energy Delivery of Ohio, to National Fuel Gas Company for $2.62 billion.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade